Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

1.

Phase II Eastern Cooperative Oncology Group Study of spirogermanium in previously treated lymphoma.

Boros L, Tsiatis AA, Neiman RS, Mann RB, Glick JH.

Cancer Treat Rep. 1986 Jul;70(7):917-8. No abstract available.

PMID:
3719586
[PubMed - indexed for MEDLINE]
2.

A phase II study of spirogermanium as second line therapy in patients with poor prognosis lymphoma. An NCI Canada Clinical Trials Group Study.

Eisenhauer E, Quirt I, Connors JM, Maroun J, Skillings J.

Invest New Drugs. 1985;3(3):307-10.

PMID:
4066225
[PubMed - indexed for MEDLINE]
3.

Phase II trial of spirogermanium in breast adenocarcinoma: a Cancer and Leukemia Group B Study.

Budman DR, Ginsberg S, Perry M, Weinberg V, Schein P, Hanson J, Coleman M, Wood W.

Cancer Treat Rep. 1982 Aug;66(8):1667-8. No abstract available.

PMID:
7105058
[PubMed - indexed for MEDLINE]
4.

Phase II study of spirogermanium in the treatment of metastatic breast cancer.

Pinnamaneni K, Yap HY, Legha SS, Blumenschein GR, Bodey GP.

Cancer Treat Rep. 1984 Sep;68(9):1197-8. No abstract available.

PMID:
6478457
[PubMed - indexed for MEDLINE]
5.

Continuous-infusion spirogermanium for the treatment of refractory carcinoma of the ovary: a phase II trial.

Kavanagh JJ, Saul PB, Copeland LJ, Gershenson DM, Krakoff IH.

Cancer Treat Rep. 1985 Jan;69(1):139-40. No abstract available.

PMID:
3967257
[PubMed - indexed for MEDLINE]
6.

Phase II trial of spirogermanium in advanced epithelial carcinoma of the ovary.

Weiselberg L, Budman DR, Schulman P, Vinciguerra V, Degnan TJ, Pasmantier M.

Cancer Treat Rep. 1982 Aug;66(8):1675-6. No abstract available.

PMID:
7201885
[PubMed - indexed for MEDLINE]
7.

Phase II trial of spirogermanium for treatment of advanced breast cancer.

Falkson G, Falkson HC.

Cancer Treat Rep. 1983 Feb;67(2):189-90. No abstract available.

PMID:
6825129
[PubMed - indexed for MEDLINE]
8.

[Metastatic cancer of the prostate: phase II study of spirogermanium (NSC 192965)].

Bui NB, Chauvergne J, Brunet R, Richaud P, Hoerni B, Lagarde C, Le Guillou M.

Bull Cancer. 1986;73(1):65-7. French.

PMID:
3779124
[PubMed - indexed for MEDLINE]
9.

A phase II study of spirogermanium in patients with metastatic malignant melanoma. An NCI Canada Clinical Trials Group Study.

Eisenhauer E, Kerr I, Bodurtha A, Iscoe N, McCulloch P, Pritchard K, Quirt I.

Invest New Drugs. 1985;3(3):303-5.

PMID:
4066224
[PubMed - indexed for MEDLINE]
10.

Phase II trial of spirogermanium in central nervous system tumors: a Southwest Oncology Group Study.

Goodwin JW, Crowley J, Tranum B, Vance R, Slavik M, Balcerzak S, Hacker D.

Cancer Treat Rep. 1987 Jan;71(1):99-100. No abstract available.

PMID:
3791276
[PubMed - indexed for MEDLINE]
11.

Phase II study of N-methylformamide, spirogermanium, and 4-demethoxydaunorubicin in the treatment of non-small cell lung cancer (EST 3583): an Eastern Cooperative Oncology Group study.

Ettinger DS, Finkelstein DM, Donehower RC, Chang AY, Green M, Blum R, Hahn RG, Ruckdeschel JC.

Med Pediatr Oncol. 1989;17(3):197-201.

PMID:
2546026
[PubMed - indexed for MEDLINE]
12.

Therapy for advanced renal cell cancer with spirogermanium: a Southwest Oncology Group Study.

Saiers JH, Slavik M, Stephens RL, Crawford ED.

Cancer Treat Rep. 1987 Feb;71(2):207-8. No abstract available.

PMID:
3802117
[PubMed - indexed for MEDLINE]
13.

Pulmonary toxicity associated with spirogermanium.

Dixon C, Hagemeister F, Legha S, Bodey G.

Cancer Treat Rep. 1984 Jun;68(6):907-8. No abstract available.

PMID:
6733705
[PubMed - indexed for MEDLINE]
14.

Phase II evaluation of spirogermanium in advanced ovarian carcinoma.

Brenner DE, Jones HW, Rosenshein NB, Forastiere A, Dillon M, Grumbine F, Tipping S, Burnett L, Greco FA, Wiernik PH.

Cancer Treat Rep. 1983 Feb;67(2):193-4. No abstract available.

PMID:
6825131
[PubMed - indexed for MEDLINE]
15.

Phase II study of spirogermanium in patients with advanced carcinoma of the cervix.

Brenner DE, Rosenshein NB, Dillon M, Jones HW, Forastiere A, Tipping S, Burnett LS, Greco FA, Wiernik PH.

Cancer Treat Rep. 1985 Apr;69(4):457-8. No abstract available.

PMID:
3995514
[PubMed - indexed for MEDLINE]
16.

Phase II trial of spirogermanium in advanced renal cell carcinoma: a Cancer and Leukemia Group B study.

Schulman P, Davis RB, Rafla S, Green M, Henderson E.

Cancer Treat Rep. 1984 Oct;68(10):1305-6. No abstract available.

PMID:
6525606
[PubMed - indexed for MEDLINE]
17.

A phase II study of spirogermanium in advanced large bowel cancer. An Eastern Cooperative Oncology Group study.

Pandya KJ, Kramar A, Asbury RF, Haller DG.

Am J Clin Oncol. 1988 Aug;11(4):496-8.

PMID:
3407630
[PubMed - indexed for MEDLINE]
18.

Phase II study of spirogermanium in advanced (extensive) non-small cell lung cancer.

Dhingra HM, Umsawasdi T, Chiuten DF, Murphy WK, Holoye PY, Spitzer G, Valdivieso M.

Cancer Treat Rep. 1986 May;70(5):673-4. No abstract available.

PMID:
3708617
[PubMed - indexed for MEDLINE]
19.

Phase II study of spirogermanium in advanced breast cancer.

Kuebler JP, Tormey DC, Harper GR, Chang YC, Khandekar JD, Falkson G.

Cancer Treat Rep. 1984 Dec;68(12):1515-6. No abstract available.

PMID:
6509457
[PubMed - indexed for MEDLINE]
20.

Phase II study of spirogermanium in metastatic prostate cancer.

Dexeus FH, Logothetis C, Samuels ML, Hossan B.

Cancer Treat Rep. 1986 Sep;70(9):1129-30. No abstract available.

PMID:
3742495
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk